Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Immunome (IMNM) Other Gross PP&E Adjustments (2019 - 2026)

Immunome filings provide 5 years of Other Gross PP&E Adjustments readings, the most recent being -$2.8 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 45.19% to -$2.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$2.8 million, a 45.19% increase, with the full-year FY2025 number at $18.0 million, up 86.8% from a year prior.
  • Other Gross PP&E Adjustments hit -$2.8 million in Q1 2026 for Immunome, down from $18.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $18.0 million in Q4 2025 to a low of -$5.3 million in Q3 2024.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$2.3 million (2023), compared with a mean of $135357.1.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 184.02% in 2024, down 527.57% in 2024.
  • Immunome's Other Gross PP&E Adjustments stood at $3.4 million in 2022, then rose by 0.92% to $3.4 million in 2023, then soared by 184.02% to $9.7 million in 2024, then skyrocketed by 86.8% to $18.0 million in 2025, then plummeted by 115.69% to -$2.8 million in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were -$2.8 million (Q1 2026), $18.0 million (Q4 2025), and -$3.9 million (Q3 2025) per Business Quant data.